Oracle Health and Baylor College of Medicine have launched a landmark collaboration to power research into alcohol-related liver disease (ALD), one of the fastest-growing causes of liver-related illness and death in America.
Using Oracle Health’s AI data platform and real datasets that hold over 120 million anonymized patient histories, Baylor hopes to build one of the nation’s largest research cohorts for ALD, expanding to more than one million patients.
Researchers will be able to identify early warning signs, study how the disease progresses, and develop more effective prevention and treatment regimens.
“Early detection is key to changing outcomes,” said Seema Verma, executive vice president and general manager at Oracle Health and Life Sciences.
“With Oracle’s advanced analytics and Baylor’s research capabilities, we can help revolutionize how this condition is being researched and treated.”
Baylor researchers will use AI-based analysis of data to determine risk factors and predictive patterns for liver disease.
The findings gathered will aim to allow clinicians to have greater diagnostic ability and advise on public health programs to abate the ALD burden in the country.
Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor, added, “By building one of the largest ALD cohorts in the country, we’re creating a critical research resource to improve early intervention and patient outcomes.”
With instances of ALD on the rise, especially among younger populations, this partnership marks an important step towards leveraging AI and healthcare data innovation to tackle one of today’s most significant medical challenges.
You may also want to check out some of our other recent updates.
Wanna know what’s trending online every day? Subscribe to Vavoza Insider to access the latest business and marketing insights, news, and trends daily with unmatched speed and conciseness! 🗞️
